| Application no. and date | 06749439.3 (espacenet) (Federated) (European Patent Register), 20060406 | | Patent/reg. no. and date | DK/EP 1874306, 20120704 | | Publication date | 20080109 | | Priority no. and date | US 669789 P, 20050408, US 787395 P, 20060330 | | EP pub. no. and date |
EP 1874306 20080109 | | Effective date | | | Applicant/owner | PTC Therapeutics, Inc., 100 Corporate Court, Middlesex Business Center
South Plainfield, NJ 07080, US | | Applicant ref. no. | P81204120DK00E | | Inventor | HIRAWAT, Samit, 602 Margaret Court
South Plainfield, New Jersey 07080, US,
MILLER, Langdon, 13 Strawberry Lane
Lebanon, New Jersey 08833, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4245 (2006.01) , A61P 11/00 (2006.01) , A61P 25/00 (2006.01) , A61P 25/28 (2006.01) , A61P 3/10 (2006.01) , A61P 35/00 (2006.01) , A61P 7/00 (2006.01) , A61P 9/00 (2006.01) | | Title | Sammensætninger af en oralt aktiv 1,2,4-oxadiazol til nonsens-mutationssuppressionsterapi | | Int. application no. | US2006012887 | | Int. publication no. | WO2006110483 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
